No abstract

No abstract

No abstract

No abstract

mailing methods. The point I would like especially to emphasize is that the gynecologist need not consider himself hamstrung or even greatly handicapped if, voluntarily or involuntarily, he does not make use of vaginal cell study. In the presence of a suspicious target lesion I would consider myself far more derelict in omitting biopsy than in omitting a vaginal smear. It is only in the screening of ostensibly normal women that vaginal smears have an advantage over biopsy, but these constitute only a small proportion, probably less than 1 per cent, of all those with cervical cancers. Even in this group